Suman VJ, Du L, Hoskin T, Anurag M, et al. Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy and longer-term breast cancer patient outcomes (Alliance Z1031). Clin Cancer Res 2022 Jun 2. pii: 699315. doi: 10.1158/1078-0432.CCR-22-0068.
PMID: 35653124